In the literature there is only one report of a fixed drug eruption due to oxyphenbutazone. We are reporting a patient whose fixed drug eruption was caused by oxyphenbutazone and who showed cross-sensitivity to phenylbutazone. There was no history of phenylbutazone having been administered to this patient earlier than the challenging test dose.
No takes yet. Share an insight, caveat, or question.
Nayyar et al. (2009) studied this question.